dos Santos, DMC; Tix, T; Shouval, R; Gafter-Gvili, A; Alberge, JB; Cliff, ERS; Theurich, S; von Bergwelt-Baildon, M; Ghobrial, IM; Subklewe, M; Perales, MA; Rejeski, K. (2024) A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy by TUMbrandherde | Jun 4, 2025
Vera-Cruz, S; Culubret, MJ; Konetzki, V; Alb, M; Friedel, SR; Hudecek, M; Einsele, H; Danhof, S; Scheller, L. (2024) Cellular Therapies for Multiple Myeloma: Engineering Hope by TUMbrandherde | Jun 4, 2025
Kazerani, M; Marcinek, A; Philipp, N; Brauchle, B; Taylor, JJ; Moreno, HD; Terrasi, A; Tast, B; Rohrbacher, L; Wang, YS; Warm, M; Emhardt, AJ; Magno, G; Spiekermann, K; Herold, T; Straub, T; Theurich, S; Schotta, G; Kischel, R; Bücklein, VL; Subklewe, M. (2024) Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse by TUMbrandherde | Jun 4, 2025
Nair, R; Salinas-Illarena, A; Sponheimer, M; Wullkopf, I; Schreiber, Y; Corte-Real, JV; Ben, AD; Marterer, H; Thomas, D; Geisslinger, G; Cinatl, J; Subklewe, M; Baldauf, HM (2024) Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia by TUMbrandherde | Jun 4, 2025
Hänel, G; Schönle, A; Neumann, AS; Nixdorf, D; Philipp, N; Sponheimer, M; Leutbecher, A; Emhardt, AJ; Magno, G; Bücklein, V; Eckmann, J; Dunshee, D; Kramar, V; Korfi, K; Colombetti, S; Umaña, P; Klein, C; Subklewe, M. (2024) Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment by TUMbrandherde | Jun 4, 2025
